How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
APPENDIX 1 --- Frequently asked questions<br />
A.1<br />
1. Why is it necessary <strong>to</strong> measure adherence?<br />
Because <strong>of</strong> the ever present threats <strong>of</strong> treatment failure and resistance.<br />
2. What use will it be <strong>to</strong> have a standardized method <strong>of</strong> measurement?<br />
Standardization is needed so that rates can be compared over time and between facilities. A<br />
manager may know:<br />
<strong>How</strong> a facility is doing at that moment<br />
<strong>How</strong> it is doing over time<br />
<strong>How</strong> it compares <strong>to</strong> other facilities<br />
To assess the effectiveness <strong>of</strong> interventions <strong>to</strong> improve adherence <strong>levels</strong>.<br />
All <strong>of</strong> these indica<strong>to</strong>rs will, in turn, give a yardstick for managers <strong>to</strong> concentrate energies<br />
and resources on poorer performing facilities for maximal system strengthening.<br />
3. Why is more than one indica<strong>to</strong>r needed?<br />
The problem with measuring adherence <strong>to</strong> ARVs is that it is a behaviour that takes place in<br />
the privacy <strong>of</strong> the patient’s home. Therefore, all measures are indirect and subject <strong>to</strong><br />
different biases and inaccuracies. <strong>How</strong>ever all <strong>of</strong> these correlate with clinical outcome.<br />
4. <strong>How</strong> do we sample facilities?<br />
See Chapter 4, opening paragraph.<br />
5. <strong>How</strong> do we sample patient records?<br />
Use Figure 1 in Chapter 4.<br />
6. Which dates do we use for dispensing and patient attendance?<br />
Use Table 6 in Chapter 4.<br />
7. Who should we have permission from <strong>to</strong> do the survey?<br />
The National AIDS Control Programme and/or a local ethical review board.<br />
8. Who should I communicate with in the facilities?<br />
It is important <strong>to</strong> ask permission from the head <strong>of</strong> the facility and let the head <strong>of</strong> the facility<br />
and the head <strong>of</strong> the HIV/AIDS clinic know your intention. It is <strong>of</strong>ten useful <strong>to</strong> communicate<br />
with the pharmacist <strong>to</strong> ensure that you are planning your visit on a day when patients are<br />
expected.